GlaxoSmithKline vs Canada: Transfer Pricing Case

he GlaxoSmithKline transfer pricing case was a landmark decision in Canadian tax law. It involved GSK’s Canadian subsidiary and the Canada Revenue Agency (CRA). The dispute centered on the pricing of ranitidine, the active ingredient in the anti-ulcer drug Zantac.

GlaxoSmithKline vs Canada: Transfer Pricing Case Read Post »